These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
107 related items for PubMed ID: 7819379
1. Determination of MK-383, a non-peptide fibrinogen receptor antagonist, in human plasma and urine by radioimmunoassay. Hand EL, Gilbert JD, Yuan AS, Olah TV, Hichens M. J Pharm Biomed Anal; 1994 Aug; 12(8):1047-53. PubMed ID: 7819379 [Abstract] [Full Text] [Related]
2. Determination of MK-852, a new fibrinogen receptor antagonist, in plasma and urine by radioimmunoassay. Yuan AS, Hand EL, Hichens M, Olah TV, Barrish A, Fernandez-Metzler C, Gilbert JD. J Pharm Biomed Anal; 1993 Jun; 11(6):427-34. PubMed ID: 8399513 [Abstract] [Full Text] [Related]
3. Determination of an endothelin receptor antagonist in rat plasma by radioimmunoassay. Yuan S, Cylc D, Hsieh JY, Matuszewski BK. J Pharm Biomed Anal; 2004 Feb 04; 34(2):391-7. PubMed ID: 15013153 [Abstract] [Full Text] [Related]
4. Use of LC-MS/MS to cross-validate a radioimmunoassay for the fibrinogen receptor antagonist, Aggrastat (tirofiban hydrochloride) in human plasma. Ellis JD, Hand EL, Gilbert JD. J Pharm Biomed Anal; 1997 Feb 04; 15(5):561-9. PubMed ID: 9127267 [Abstract] [Full Text] [Related]
5. Pharmacokinetics and pharmacodynamics of MK-383, a selective non-peptide platelet glycoprotein-IIb/IIIa receptor antagonist, in healthy men. Barrett JS, Murphy G, Peerlinck K, De Lepeleire I, Gould RJ, Panebianco D, Hand E, Deckmyn H, Vermylen J, Arnout J. Clin Pharmacol Ther; 1994 Oct 04; 56(4):377-88. PubMed ID: 7955799 [Abstract] [Full Text] [Related]
6. In vitro and in vivo studies on the metabolism of tirofiban. Vickers S, Theoharides AD, Arison B, Balani SK, Cui D, Duncan CA, Ellis JD, Gorham LM, Polsky SL, Prueksaritanont T, Ramjit HG, Slaughter DE, Vyas KP. Drug Metab Dispos; 1999 Nov 04; 27(11):1360-6. PubMed ID: 10534322 [Abstract] [Full Text] [Related]
7. Radioimmunoassay of nicergoline in biological material. Bizollon CA, Rocher JP, Chevalier P. Eur J Nucl Med; 1982 Nov 04; 7(7):318-21. PubMed ID: 7117274 [Abstract] [Full Text] [Related]
8. MK-383 (L-700,462), a selective nonpeptide platelet glycoprotein IIb/IIIa antagonist, is active in man. Peerlinck K, De Lepeleire I, Goldberg M, Farrell D, Barrett J, Hand E, Panebianco D, Deckmyn H, Vermylen J, Arnout J. Circulation; 1993 Oct 04; 88(4 Pt 1):1512-7. PubMed ID: 8403299 [Abstract] [Full Text] [Related]
9. The evaluation of a radioimmunoassay for phenothiazines and thioxanthenes using an iodinated tracer. Rowell FJ, Hui SM, Paxton JW. J Immunol Methods; 1979 Oct 04; 31(1-2):159-66. PubMed ID: 512372 [Abstract] [Full Text] [Related]
10. Validation of a radioimmunoassay for the determination of human plasma concentrations of lamotrigine. Biddlecombe RA, Dean KL, Smith CD, Jeal SC. J Pharm Biomed Anal; 1990 Oct 04; 8(8-12):691-4. PubMed ID: 2100608 [Abstract] [Full Text] [Related]
11. Determination of an echinocandin, MK-0991, in mammalian plasma by radioimmunoassay. Yuan AS, Cylc D, Hsieh JY, Matuszewski BK. J Pharm Biomed Anal; 2001 Jul 04; 25(5-6):811-20. PubMed ID: 11377064 [Abstract] [Full Text] [Related]
12. Determination of L-691,121, a new class III antiarrhythmic, and its principal metabolite in plasma by differential radioimmunoassay. Greber TF, Olah TV, Gilbert JD, Porras AG, Hichens M. J Pharm Biomed Anal; 1994 Apr 04; 12(4):483-92. PubMed ID: 7918764 [Abstract] [Full Text] [Related]
13. Radioimmunological determination of fenoterol. Part II: Antiserum and tracer for the determination of fenoterol. Rominger KL, Mentrup A, Stiasni M. Arzneimittelforschung; 1990 Aug 04; 40(8):887-95. PubMed ID: 2242081 [Abstract] [Full Text] [Related]
14. Effects of tirofiban plus heparin versus heparin alone on troponin I levels in patients with acute coronary syndromes. Januzzi JL, Hahn SS, Chae CU, Giugliano R, Lewandrowski K, Theroux P, Jang IK. Am J Cardiol; 2000 Oct 01; 86(7):713-7. PubMed ID: 11018188 [Abstract] [Full Text] [Related]
15. A radioimmunoassay procedure for tallysomycin S10b in human plasma and urine. Gaver RC, Dixon CW, Smyth RD. Cancer Chemother Pharmacol; 1986 Oct 01; 16(3):207-10. PubMed ID: 2421934 [Abstract] [Full Text] [Related]
16. Non-peptide fibrinogen receptor antagonists. 2. Optimization of a tyrosine template as a mimic for Arg-Gly-Asp. Egbertson MS, Chang CT, Duggan ME, Gould RJ, Halczenko W, Hartman GD, Laswell WL, Lynch JJ, Lynch RJ, Manno PD. J Med Chem; 1994 Aug 05; 37(16):2537-51. PubMed ID: 8057299 [Abstract] [Full Text] [Related]
17. Non-peptide fibrinogen receptor antagonists. 1. Discovery and design of exosite inhibitors. Hartman GD, Egbertson MS, Halczenko W, Laswell WL, Duggan ME, Smith RL, Naylor AM, Manno PD, Lynch RJ, Zhang G. J Med Chem; 1992 Nov 27; 35(24):4640-2. PubMed ID: 1469694 [No Abstract] [Full Text] [Related]
18. The development and cross-validation of methods based on radioimmunoassay and LC/MS-MS for the quantification of the class III antiarrhythmic agent, MK-0499, in human plasma and urine. Gilbert JD, Greber TF, Ellis JD, Barrish A, Olah TV, Fernández-Metzler C, Yuan AS, Burke CJ. J Pharm Biomed Anal; 1995 Jul 27; 13(8):937-50. PubMed ID: 8580153 [Abstract] [Full Text] [Related]
19. Radioimmunoassay of bleomycin in plasma and urine. Teale JD, Clough JM, Marks V. Br J Cancer; 1977 Jun 27; 35(6):822-7. PubMed ID: 68783 [Abstract] [Full Text] [Related]
20. Radioimmunoassay for the determination of alosetron in human urine and saliva. Wring SA, O'Neill RM, Williams JL, Birch HL, Goddard CP, Andrew PD, Jenner WN. Analyst; 1994 Nov 27; 119(11):2395-401. PubMed ID: 7872486 [Abstract] [Full Text] [Related] Page: [Next] [New Search]